explore -WSS

explore

author：knowledge 2025-09-27 12:21:49 - browse：73647

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： A new House health package & hospitals’ new site

WSS

FDA approves world's first CRISPR

Teach medical students about patients with intellectual disabilities

Spinal cord stimulation reduces pain in amputees, study finds

Crinetics acromegaly drug succeeds in late

What drug price negotiations mean for Medicare Part D

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

hotspot

explore

focus

Novavax promises a turnaround & Lilly roils the obesity market

Pfizer plans to depart BIO

Jerome Adams on the need for new antivirals for Covid

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Medicare details structure of new drug price negotiation program

What PEPFAR has meant on the ground in Ukraine

In age of alternative facts, a scholarly course on calling out crap

Pharma patents targeted by Biden in move to slash drug prices

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicaid rebukes states for mistakenly disenrolling children

explore

Americans' trust in science, scientist continues decline: Report

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Radiology is caught between AI's potential and concern for patients

Crinetics acromegaly drug succeeds in late

How to fix cancer clinical trials' diversity problem

Roche to buy Carmot Therapeutics, developer of obesity drugs

entertainment

hotspot

focus

focus